Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 26Neoplasms 18Prostatic Neoplasms 11Lung Neoplasms 7Sarcoma 6Pancreatic Neoplasms 5Ovarian Neoplasms 5Colorectal Neoplasms 5Uterine Cervical Neoplasms 4Head and Neck Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Oropharyngeal Neoplasms 3Lymphoma 3Hematologic Neoplasms 3Esophageal Neoplasms 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Signs and Symptoms 2Papillomavirus Infections 2Pain 2Multiple Myeloma 2Melanoma 2Gastrointestinal Neoplasms 2Financial Stress 2Endometrial Neoplasms 2Depression 2Coitus 2Chronic Pain 2Central Nervous System Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2

Interventions

Surveys and Questionnaires 1Polyethylene Glycols 1Pharmacogenomic Testing 1Oxycodone 1Nerve Growth Factor 1Magnesium Hydroxide 1Fentanyl 1Electrolytes 1Dosage Forms 1Control Groups 1Antibodies 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Cancer Pain × Surveys and Questionnaires × Clear all
NCT06728579 2026-04-17

Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
200 enrolled

Cancer Pain, Pain, Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡